Comerica Bank’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.96M Buy
40,318
+2,494
+7% +$183K 0.01% 936
2025
Q1
$4.32M Sell
37,824
-817
-2% -$93.3K 0.02% 741
2024
Q4
$1.95M Buy
38,641
+600
+2% +$30.2K 0.01% 1156
2024
Q3
$1.76M Buy
38,041
+7,200
+23% +$333K 0.01% 1215
2024
Q2
$1M Sell
30,841
-1,754
-5% -$57K ﹤0.01% 1492
2024
Q1
$821K Sell
32,595
-4,659
-13% -$117K ﹤0.01% 1643
2023
Q4
$1.21M Buy
37,254
+203
+0.5% +$6.59K 0.01% 1440
2023
Q3
$1.01M Buy
37,051
+8,079
+28% +$220K 0.01% 1451
2023
Q2
$1 Buy
+28,972
New +$1 ﹤0.01% 641
2022
Q4
$1.21M Sell
52,695
-16,145
-23% -$370K 0.01% 1353
2022
Q3
$2M Sell
68,840
-8,570
-11% -$248K 0.02% 1041
2022
Q2
$2.15M Sell
77,410
-370
-0.5% -$10.3K 0.02% 1056
2022
Q1
$1.79M Sell
77,780
-1,975
-2% -$45.4K 0.01% 1224
2021
Q4
$1.39M Sell
79,755
-10,142
-11% -$177K 0.01% 1384
2021
Q3
$1.68M Sell
89,897
-3,477
-4% -$65.1K 0.01% 1405
2021
Q2
$1.9M Sell
93,374
-8,087
-8% -$165K 0.01% 1336
2021
Q1
$2.44M Sell
101,461
-3,602
-3% -$86.4K 0.01% 1240
2020
Q4
$2.95M Buy
105,063
+257
+0.2% +$7.21K 0.02% 1049
2020
Q3
$1.87M Sell
104,806
-303
-0.3% -$5.41K 0.01% 1170
2020
Q2
$1.72M Buy
105,109
+5,237
+5% +$85.5K 0.01% 1179
2020
Q1
$1.31M Buy
99,872
+3,432
+4% +$45.1K 0.01% 1175
2019
Q4
$1.26M Buy
96,440
+772
+0.8% +$10.1K 0.01% 1408
2019
Q3
$1.35M Sell
95,668
-2,501
-3% -$35.3K 0.01% 1344
2019
Q2
$1.05M Sell
98,169
-5,151
-5% -$54.9K 0.01% 1507
2019
Q1
$1.27M Buy
103,320
+1,561
+2% +$19.1K 0.01% 1435
2018
Q4
$1.19M Sell
101,759
-460
-0.5% -$5.37K 0.01% 1441
2018
Q3
$1.25M Sell
102,219
-41,264
-29% -$506K 0.01% 1459
2018
Q2
$1.99M Buy
143,483
+43,464
+43% +$604K 0.01% 1267
2018
Q1
$1.82M Buy
100,019
+2,812
+3% +$51.1K 0.01% 1285
2017
Q4
$2.44M Buy
+97,207
New +$2.44M 0.02% 1142